Begrænsede kliniske data viser at patienter med ubetydelig eller ikke- målelig plasmakoncentration af metabolitten ikke udviste et nedsat virologisk respons eller en anderledes sikkerhedsprofil end populationen i hele studiet.
Limited clinical data suggest that patients with very low or non-measurable plasma concentrations of the metabolite and elevated concentrations of nelfinavir do not show a reduced virological response or a different safety profile when compared with the whole study population.